CHEMOTHERAPY NEUROTOXICITY ATTENUATION

CHEMOTHERAPY NEUROTOXICITY ATTENUATION was reported 9 times

CHEMOTHERAPY NEUROTOXICITY ATTENUATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 2 0.0002
1 Human Immunoglobulin G [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
4 Expectorant [EPC] 2 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
6 Alkylating Drug [EPC] 2 0.0000
7 Anti-epileptic Agent [EPC] 1 0.0000
8 Loop Diuretic [EPC] 2 0.0000
9 Platinum-based Drug [EPC] 1 0.0000
10 Corticosteroid [EPC] 3 0.0000
11 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000